+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Biosensors Market Size, Share & Trends Analysis Report by Technology (Electrochemical, Thermal, Piezoelectric), Application (Medical, Food Toxicity, Bioreactor), End-use, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 80 Pages
  • May 2024
  • Region: United States
  • Grand View Research
  • ID: 5976464
The U.S. biosensors market size is anticipated to reach USD 15.61 billion by 2030 and is projected to grow at a CAGR of 7.13% from 2024 to 2030. It encompasses various biosensor devices, components, technologies, and services used across multiple industries, such as healthcare, food safety, environmental monitoring, agriculture, biotechnology, and security.

The U.S. market is experiencing significant growth driven by a combination of factors. One key driver is the increasing demand for point-of-care testing (POCT) solutions, which offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings.

Biosensors play a crucial role in diagnosing, monitoring, and managing these conditions, driving demand for innovative biosensor solutions. Regulatory support and approvals for biosensor technologies and a growing emphasis on personalized medicine are also contributing to market expansion. For instance, the FoundationOne CDx test, approved by the FDA, is a companion diagnostic utilizing next-generation sequencing to detect advanced cancer patients who could potentially benefit from targeted therapies. The test uses biosensors to examine tumor DNA to provide details on actionable genomic alterations.

U.S. Biosensors Market Report Highlights

  • Based on technology, the electrochemical segment led the market with the largest revenue share of 72.86% in 2023, due to its diverse use across various sectors and industries, these biosensors can be miniaturized and integrated into portable devices such as personal glucose meter that provides fast measurement of blood glucose levels for personal glycemic management
  • Based on application, the medical segment led the market with the largest revenue share of 65.57%in 2023, due to the rapid and accurate diagnostic tools, emphasis on personalized medicine, advancements in healthcare technology, and others. For instance, in November 2021, Quanterix, a U.S.-based company specializing in digital biomarker solutions, announced the release of its Simoa Ultra-Sensitive Biosensors Platform. This platform empowers the detection of low-abundance biomarkers associated with various diseases
  • Based on end-use, the point of care (PoC) testing segment led the market with the largest revenue share of 47.67% in 2023, due to their demand in various settings including clinics, pharmacies, and emergency departments

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology Outlook
2.2.2. Application Outlook
2.2.3. End-use Outlook
2.3. Competitive Insights
Chapter 3. U.S. Biosensors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
3.3.2.4. Social Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Environmental Landscape
Chapter 4. U.S. Biosensors Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Biosensors Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Thermal
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Electrochemical
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3. Piezoelectric
4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.4. Optical
4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Biosensors Market: Application Estimates & Trend Analysis
5.1. Product Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Biosensors Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Medical
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. Food Toxicity
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. Bioreactor
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.4. Agriculture
5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.5. Environment
5.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Biosensors Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Biosensors Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Home Healthcare Diagnostics
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. PoC Testing
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Food Industry
6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.4. Research Laboratories
6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.5. Security and Bio-defense
6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Biosensors Market: Region Estimates & Trend Analysis
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Biosensors Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. Midwest
7.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of Key Distributors and Channel Partners
8.3.2. Key Customers
8.3.3. Key Company Heat Map Analysis, 2023
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Medtronic
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Hoffmann-La Roche Ltd
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Dexcom, Inc.
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. SENTINEL
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Intricon Corporation
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Quanterix
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Koninklijke Philips N.V.
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Masimo
8.4.9.1. Company Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Siemens Healthcare Private Limited
8.4.10.1. Company Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Molecular Devices, LLC.
8.4.11.1. Company Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Johnson & Johnson Services, Inc.
8.4.12.1. Company Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Thermo Fisher Scientific Inc.
8.4.13.1. Company Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. PerkinElmer Inc.
8.4.14.1. Company Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives
8.4.15. Covaris, LLC
8.4.15.1. Company Overview
8.4.15.2. Financial Performance
8.4.15.3. Product Benchmarking
8.4.15.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.S. Biosensors Market, by Technology, 2018-2030 (USD Million and Volume Unit)
Table 3 U.S. Biosensors Market, by Application, 2018-2030 (USD Million and Volume Unit)
Table 4 U.S. Biosensors Market, by End-use, 2018-2030 (USD Million and Volume Unit)
Table 5 U.S. Biosensors Market, by Region, 2018-2030 (USD Million and Volume Unit)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 U.S. Biosensors Market: Market Outlook
Figure 9 U.S. Clinical Trial Supplies Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 U.S. Biosensors Market Driver Impact
Figure 14 U.S. Biosensors Market Restraint Impact
Figure 15 U.S. Biosensors Market: Technology Movement Analysis
Figure 16 U.S. Biosensors Market: Technology Outlook and Key Takeaways
Figure 17 Thermal Market Estimates and Forecast, 2018-2030 (USD Million and Volume Unit)
Figure 18 Electrochemical Market Estimates and Forecast, 2018-2030 (USD Million and Volume Unit)
Figure 19 Piezoelectric Market Estimates and Forecast, 2018-2030 (USD Million and Volume Unit)
Figure 20 Optical Market Estimates and Forecast, 2018-2030 (USD Million and Volume Unit)
Figure 21 U.S. Biosensors Market: Application Movement Analysis
Figure 22 U.S. Biosensors Market: Application Outlook and Key Takeaways
Figure 23 Medical Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 24 Food Toxicity Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 25 Bioreactor Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 26 Agriculture Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 27 Environment Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 28 Others Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 29 U.S. Biosensors Market: End-use Movement Analysis
Figure 30 U.S. Biosensors Market: End-use Outlook and Key Takeaways
Figure 31 Home Healthcare Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 32 PoC Testing Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 33 Food Industry Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 34 Research Laboratories Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 35 Security and Bio-defense Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 36 U.S. Pediatric Home Healthcare Market: Regional Movement Analysis
Figure 37 U.S. Pediatric Home Healthcare Market: Regional Outlook and Key Takeaways
Figure 38 West Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 39 Midwest Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 40 Northeast Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 41 Southwest Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)
Figure 42 Southeast Market Estimates and Forecasts, 2018-2030 (USD Million and Volume Unit)

Companies Mentioned

  • Abbott
  • Medtronic
  • Hoffmann-La Roche Ltd
  • Dexcom, Inc.
  • SENTINEL
  • Intricon Corporation
  • Quanterix
  • Koninklijke Philips N.V.
  • Masimo
  • Siemens Healthcare Private Limited
  • Molecular Devices, LLC.
  • Johnson & Johnson Services, Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Covaris, LLC

Methodology

Loading
LOADING...

Table Information